Table S1. Metastatic Assay Gene List including Prostate Metastatic Assay gene weightings and bias. Table S2. Summary of Clinical Characteristics of the patient samples used for analytical assessment. Table S3. A Metastatic Assay calls between the microarray and Nanostring nCounter速 platforms. B Agreement in Metastatic Assay call between the microarray and Nanostring nCounter速 platforms. Table S4. A Metastatic Assay calls between the microarray and RNA sequencing platforms. B Agreement in Metastatic Assay call between the microarray and RNA sequencing platforms. Figure S1. Scatter plot of Metastatic Assay scores between the microarray and Nanostring nCounter速 platforms. Each data point represents the assay score of the same sample profiled o...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...
120 RNA-seq datasets generated from clinical tissues of human metastatic castration resistant prosta...
Table S1. Primer sequences for β-Actin, miR-34b/c, and miR-193b (panel #1). Table S2. Scorpion prime...
Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. ...
Table S1. Correlations. Spearman’s rank correlations for the PMR values of each biomarker, ProCUrE, ...
Gene list. Table S2. Pathway list and genes in the pathway. Table S3. Scale and center data used for...
Supplemental Methods, Figures and Tables for bioinformatic analysis. Table S1. Datasets used in this...
Kaplan-Meier plots showing relationship of clinical parameters with patient outcome. Both cohort of ...
Additional file 1: Supplement Fig. 1. Survival curves for patients with different risk score accordi...
Table S1. Large-Panel NGS Microsatellite Loci. Table S2. Detail on Samples, Targeted Sequencing, Mic...
Figure S1. Box-plots of panel #1 (miR-34b/c, miR-193b) and panel #2 (APC, GSTP1, and RARβ2) promoter...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Table S1. Pathological and clinical data of the arrayed prostate cancers. Table S2. Association betw...
Percentage of patients of the top ten biomarkers at each level of evidence in each tumor type. Level...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...
120 RNA-seq datasets generated from clinical tissues of human metastatic castration resistant prosta...
Table S1. Primer sequences for β-Actin, miR-34b/c, and miR-193b (panel #1). Table S2. Scorpion prime...
Table S1. Data description of TCGA RNA sequencing data. Table S2. List of antibody-drug conjugates. ...
Table S1. Correlations. Spearman’s rank correlations for the PMR values of each biomarker, ProCUrE, ...
Gene list. Table S2. Pathway list and genes in the pathway. Table S3. Scale and center data used for...
Supplemental Methods, Figures and Tables for bioinformatic analysis. Table S1. Datasets used in this...
Kaplan-Meier plots showing relationship of clinical parameters with patient outcome. Both cohort of ...
Additional file 1: Supplement Fig. 1. Survival curves for patients with different risk score accordi...
Table S1. Large-Panel NGS Microsatellite Loci. Table S2. Detail on Samples, Targeted Sequencing, Mic...
Figure S1. Box-plots of panel #1 (miR-34b/c, miR-193b) and panel #2 (APC, GSTP1, and RARβ2) promoter...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Table S1. Pathological and clinical data of the arrayed prostate cancers. Table S2. Association betw...
Percentage of patients of the top ten biomarkers at each level of evidence in each tumor type. Level...
Table S1. 48 genes included in the TruSeq Amplicon Cancer Panel (TSACP, Illumina), which includes 21...
Table S1. Growth media for breast cancer cell lines used in study. Table S2. PTEN protein abundance ...
120 RNA-seq datasets generated from clinical tissues of human metastatic castration resistant prosta...